1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Biopharmaceutical Industry in Germany Market Research & Statistics

Biopharmaceutical Industry in Germany Market Research & Statistics

24/7 Customer Support

Talk to Sam

+1 646 893 5945

All regions

56 reports

Download Unlimited Documents from Trusted Public Sources

Biopharmaceutical Industry in Germany

  • December 2016
    13 pages
  • Biopharmaceutic...  

  • Germany  

    Europe  

View report >

Biopharmaceutical Industry in Germany

  • July 2015
    12 pages
  • Biopharmaceutic...  

  • Germany  

View report >

Erythropoietin Industry in Germany and Iran

  • May 2017
    8 pages
  • Erythropoietin  

  • Germany  

    Iran  

View report >

Allergy Drug Supply in Germany

  • March 2017
    3 pages
  • Allergy Drug  

    Biopharmaceutic...  

  • Germany  

View report >

Therapy Market in Germany

  • June 2016
    2 pages
  • Biopharmaceutic...  

  • Germany  

    Europe  

View report >

Biosimilar Price Decrease in Germany and France

  • January 2016
  • Biosimilar  

  • Germany  

    France  

    Europe  

View report >

Biosimilar Market Drivers in Germany - Forecast

  • January 2016
  • Biosimilar  

    Immunology  

  • Germany  

    Europe  

View report >

Biosimilar Industry in Germany and Europe

  • January 2016
    14 pages
  • Biosimilar  

    Pharmaceutical  

  • Germany  

    Europe  

View report >


2 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 7500 - $ 7500)

Psoriatic Arthritis Pricing, Reimbursement, and Access

  • $ 7500
  • Industry report
  • June 2016
  • by Datamonitor Healthcare

An absence of head-to-head trials, along with biosimilar launches, provide payers with leverage to demand favorable pricing for branded products in exchange for formulary access. This report addresses ...

Psoriatic Arthritis Pricing, Reimbursement, And Access

June 2016 $ 7500

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.